Compare NTB & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTB | INMD |
|---|---|---|
| Founded | 1858 | 2008 |
| Country | Bermuda | Israel |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 842.0M |
| IPO Year | 2016 | 2018 |
| Metric | NTB | INMD |
|---|---|---|
| Price | $59.67 | $14.80 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 5 |
| Target Price | ★ $53.75 | $17.33 |
| AVG Volume (30 Days) | 212.9K | ★ 739.4K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.66% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.84 | $1.74 |
| Revenue Next Year | $4.16 | $3.26 |
| P/E Ratio | ★ $9.64 | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $40.59 | $12.72 |
| 52 Week High | $60.87 | $16.74 |
| Indicator | NTB | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 58.67 | 66.80 |
| Support Level | $57.71 | $14.58 |
| Resistance Level | N/A | $15.23 |
| Average True Range (ATR) | 1.02 | 0.27 |
| MACD | 0.03 | 0.14 |
| Stochastic Oscillator | 62.09 | 80.30 |
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.